Connor, Clark & Lunn Investment Management Ltd. Merck & Co., Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.8 Billion
- Q1 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 304,442 shares of MRK stock, worth $37.7 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
304,442
Previous 1,286,224
76.33%
Holding current value
$37.7 Million
Previous $140 Million
71.35%
% of portfolio
0.18%
Previous 0.7%
Shares
28 transactions
Others Institutions Holding MRK
# of Institutions
3,766Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.1 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$25.6 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.5 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.7 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$6.98 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $314B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...